These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 12885425)
1. Membrane and synaptic effects of corticotropin-releasing factor on periaqueductal gray neurons of the rat. Bowers LK; Swisher CB; Behbehani MM Brain Res; 2003 Aug; 981(1-2):52-7. PubMed ID: 12885425 [TBL] [Abstract][Full Text] [Related]
2. Actions of epinephrine on neurons in the rat midbrain periaqueductal gray maintained in vitro. Jiang M; Chandler SD; Ennis M; Shipley MT; Behbehani MM Brain Res Bull; 1992 Dec; 29(6):871-7. PubMed ID: 1335350 [TBL] [Abstract][Full Text] [Related]
3. Corticotropin-releasing hormone modulates airway vagal preganglionic neurons of Sprague-Dawley rats at multiple synaptic sites via activation of its type 1 receptors: Implications for stress-associated airway vagal excitation. Guo Y; Yan X; Chen X; He D; Zeng M; Chen Y; Xia C; Qiu D; Wang J Neuroscience; 2017 Jul; 355():101-112. PubMed ID: 28499969 [TBL] [Abstract][Full Text] [Related]
4. Effect of the {mu} opioid on excitatory and inhibitory synaptic inputs to periaqueductal gray-projecting neurons in the amygdala. Finnegan TF; Chen SR; Pan HL J Pharmacol Exp Ther; 2005 Feb; 312(2):441-8. PubMed ID: 15388784 [TBL] [Abstract][Full Text] [Related]
6. Chronic cocaine enhances corticotropin-releasing factor-dependent potentiation of excitatory transmission in ventral tegmental area dopamine neurons. Hahn J; Hopf FW; Bonci A J Neurosci; 2009 May; 29(20):6535-44. PubMed ID: 19458224 [TBL] [Abstract][Full Text] [Related]
7. Inhibition by opioids acting on mu-receptors of GABAergic and glutamatergic postsynaptic potentials in single rat periaqueductal gray neurones in vitro. Chieng B; Christie MJ Br J Pharmacol; 1994 Sep; 113(1):303-9. PubMed ID: 7812626 [TBL] [Abstract][Full Text] [Related]
8. Activation of serotonin1A receptors inhibits midbrain periaqueductal gray neurons of the rat. Behbehani MM; Liu H; Jiang M; Pun RY; Shipley MT Brain Res; 1993 May; 612(1-2):56-60. PubMed ID: 8330213 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the effect of cholecystokinin (CCK) on neurons in the periaqueductal gray of the rat: immunocytochemical and in vivo and in vitro electrophysiological studies. Liu H; Chandler S; Beitz AJ; Shipley MT; Behbehani MM Brain Res; 1994 Apr; 642(1-2):83-94. PubMed ID: 8032904 [TBL] [Abstract][Full Text] [Related]
11. The neuropeptide corticotropin-releasing factor regulates excitatory transmission and plasticity at the climbing fibre-Purkinje cell synapse. Schmolesky MT; De Ruiter MM; De Zeeuw CI; Hansel C Eur J Neurosci; 2007 Mar; 25(5):1460-6. PubMed ID: 17425571 [TBL] [Abstract][Full Text] [Related]
12. Cholecystokinin-8S-induced intracellular calcium signaling in acutely isolated periaqueductal gray neurons of the rat. Yang YM; Chung JM; Rhim H Biol Pharm Bull; 2007 Feb; 30(2):297-302. PubMed ID: 17268069 [TBL] [Abstract][Full Text] [Related]
13. Importance of pituitary and brain receptors for corticotrophin-releasing factor in modulating alcohol-induced ACTH secretion in the rat. Rivier C; Rivier J; Lee S Brain Res; 1996 May; 721(1-2):83-90. PubMed ID: 8793087 [TBL] [Abstract][Full Text] [Related]
14. The effects of diphenhydramine and SR142948A on periaqueductal gray neurons and on the interactions between the medial preoptic nucleus and the periaqueductal gray. Kreitel KD; Swisher CB; Behbehani MM Neuroscience; 2002; 114(4):935-43. PubMed ID: 12379249 [TBL] [Abstract][Full Text] [Related]
15. Effects of corticotropin-releasing factor on intermediolateral cell column neurons of newborn rats. Tanabe A; Onimaru H; Suzuki H; Takeyama Y; Homma I Auton Neurosci; 2012 Nov; 171(1-2):36-40. PubMed ID: 23151516 [TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis. Kash TL; Winder DG Neuropharmacology; 2006 Oct; 51(5):1013-22. PubMed ID: 16904135 [TBL] [Abstract][Full Text] [Related]
17. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain. Owens MJ; Knight DL; Ritchie JC; Nemeroff CB J Pharmacol Exp Ther; 1991 Feb; 256(2):787-94. PubMed ID: 1847212 [TBL] [Abstract][Full Text] [Related]
18. Corticotropin-releasing factor and urocortin regulate spine and synapse formation: structural basis for stress-induced neuronal remodeling and pathology. Gounko NV; Swinny JD; Kalicharan D; Jafari S; Corteen N; Seifi M; Bakels R; van der Want JJ Mol Psychiatry; 2013 Jan; 18(1):86-92. PubMed ID: 22547117 [TBL] [Abstract][Full Text] [Related]
19. Differential actions of corticotropin releasing factor on basolateral and central amygdaloid neurones, in vitro. Rainnie DG; Fernhout BJ; Shinnick-Gallagher P J Pharmacol Exp Ther; 1992 Nov; 263(2):846-58. PubMed ID: 1331417 [TBL] [Abstract][Full Text] [Related]
20. Corticotropin releasing factor dose-dependently modulates excitatory synaptic transmission in the noradrenergic nucleus locus coeruleus. Prouty EW; Waterhouse BD; Chandler DJ Eur J Neurosci; 2017 Mar; 45(5):712-722. PubMed ID: 27973694 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]